Get started
Author

Samantha Decandia

Observed names: Decandia S, S Decandia
OpenAlex ID: A5023749417
Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells
2007 · Francesca Spinella, Laura Rosanò, et al. · Cancer Research · 97
Green tea polyphenol epigallocatechin-3-gallate inhibits the endothelin axis and downstream signaling pathways in ovarian carcinoma
2006 · Francesca Spinella, Laura Rosanò, et al. · Molecular Cancer Therapeutics · 92
Endothelin-1 is required during epithelial to mesenchymal transition in ovarian cancer progression.
2006 · Laura Rosanò, Francesca Spinella, et al. · PubMed · 40
Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target.
2006 · Francesca Spinella, Laura Rosanò, et al. · PubMed · 31
ZD4054, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma cell proliferation.
2006 · Laura Rosanò, Valeriana Di Castro, et al. · PubMed · 23
Protein Expression of p15 and p21 Plays an Unfavorable Prognostic Role in Adult Acute Lymphoblastic Leukemia (ALL) Patients Independently of Their Gene Promoter Methylation Status.
2007 · Fabiana De Cave, Maria Teresa Petrucci, et al. · Blood · 3
Synergistic Induction of Apoptosis in Multiple Myeloma Cells by Simultaneous Inhibition of the Raf/MEK/ERK and BCL-2 Pathways
2008 · Maria Rosaria Ricciardi, Michele Milella, et al. · Blood · 2
Simultaneous Targeting of Bcl-2/Bcl-Xl and MEK/ERK Results in Highly Synergistic Induction of Apoptosis in Human AML, Both in Vitro and In Vivo.
2009 · Marina Konopleva, Michele Milella, et al. · Blood · 1
Development of Mek inhibition (MEK-I)-Based Therapeutic Strategies in Acute Myeloid Leukemia (AML)
2008 · Michele Milella, Maria Rosaria Ricciardi, et al. · Blood · 1
The BCL-2 Antagonist ABT-737 Is Highly Effective on Primary Acute Lymphoblastic Leukemia Cells.
2007 · Maria Rosaria Ricciardi, Chiara Gregorj, et al. · Blood · 1
Data from Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells
2023 · Francesca Spinella, Laura Rosanò, et al.
Supplementary Figure 2 from Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells
2023 · Francesca Spinella, Laura Rosanò, et al.
PDF
Supplementary Figure 1 from Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells
2023 · Francesca Spinella, Laura Rosanò, et al.
Supplementary Figure 1 from Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells
2023 · Francesca Spinella, Laura Rosanò, et al.
PDF
Supplementary Figure 3 from Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells
2023 · Francesca Spinella, Laura Rosanò, et al.
Supplementary Figure Legends 1-4 from Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells
2023 · Francesca Spinella, Laura Rosanò, et al.
PDF
Supplementary Figure 4 from Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells
2023 · Francesca Spinella, Laura Rosanò, et al.
Supplementary Figure 4 from Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells
2023 · Francesca Spinella, Laura Rosanò, et al.
PDF
Data from Endothelin-1 and Endothelin-3 Promote Invasive Behavior via Hypoxia-Inducible Factor-1α in Human Melanoma Cells
2023 · Francesca Spinella, Laura Rosanò, et al.
Preclinical Study to Sensitize Acute Lymphoblastic Leukemia Primary Cells by Combined mTOR and BCL-2 Inhibition with CCI-779 and ABT-737.
2009 · Maria Rosaria Ricciardi, Samantha Decandia, et al. · Blood
Parallel Signaling through PI3K/AKT/mTOR Mediates Resistance to MEK Inhibition in Preclinical Models of Acute Myeloid Leukemia (AML): Synergistic Effects of Combined MEK and mTOR Inhibition.
2009 · Maria Rosaria Ricciardi, Twee Tsao, et al. · Blood
Preclinical Approach to Sensitize Multiple Myeloma Cells: Combination of the MEK Inhibitor PD0325901 with ABT-737 or Mevinolin.
2009 · Maria Rosaria Ricciardi, Elisabetta Calabrese, et al. · Blood
B267 MEK/ERK and Mevalonate Pathways Inhibition in Multiple Myeloma
2009 · MR Ricciardi, M Milella, et al. · Clinical Lymphoma & Myeloma
Combined Bcl-2 and m-TOR signal transduction inhibition in acute Lymphoblastic leukemia.
2009 · Samantha Decandia, Maria Rosaria Ricciardi, et al.
Multiple Strategies Based on MEK, mTOR and BCL-2 Signal Transduction Inhibition in Acute Lymphoblastic Leukemia (ALL)
2008 · Maria Rosaria Ricciardi, Samantha Decandia, et al. · Blood
Works count: 29
Citation count: 291
H-index: 5
I10-index: 5
Year
Topic
Type